Suppr超能文献

健康人群与健康利润?构建一个用于管控非传染性疾病商业决定因素的概念框架并确定降低风险暴露的选项。

Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.

作者信息

Buse Kent, Tanaka Sonja, Hawkes Sarah

机构信息

UNAIDS, Geneva, Switzerland.

, Paris, France.

出版信息

Global Health. 2017 Jun 15;13(1):34. doi: 10.1186/s12992-017-0255-3.

Abstract

BACKGROUND

Non-communicable diseases (NCDs) represent a significant threat to human health and well-being, and carry significant implications for economic development and health care and other costs for governments and business, families and individuals. Risks for many of the major NCDs are associated with the production, marketing and consumption of commercially produced food and drink, particularly those containing sugar, salt and transfats (in ultra-processed products), alcohol and tobacco. The problems inherent in primary prevention of NCDs have received relatively little attention from international organizations, national governments and civil society, especially when compared to the attention paid to secondary and tertiary prevention regimes (i.e. those focused on provision of medical treatment and long-term clinical management). This may in part reflect that until recently the NCDs have not been deemed a priority on the overall global health agenda. Low political priority may also be due in part to the complexity inherent in implementing feasible and acceptable interventions, such as increased taxation or regulation of access, particularly given the need to coordinate action beyond the health sector. More fundamentally, governing determinants of risk frequently brings public health into conflict with the interests of profit-driven food, beverage, alcohol and tobacco industries.

MATERIALS

We use a conceptual framework to review three models of governance of NCD risk: self-regulation by industry; hybrid models of public-private engagement; and public sector regulation. We analyse the challenges inherent in each model, and review what is known (or not) about their impact on NCD outcomes.

CONCLUSION

While piecemeal efforts have been established, we argue that mechanisms to control the commercial determinants of NCDs are inadequate and efforts at remedial action too limited. Our paper sets out an agenda to strengthen each of the three governance models. We identify reforms that will be needed to the global health architecture to govern NCD risks, including to strengthen its ability to consolidate the collective power of diverse stakeholders, its authority to develop and enforce clear measures to address risks, as well as establish monitoring and rights-based accountability systems across all actors to drive measurable, equitable and sustainable progress in reducing the global burden of NCDs.

摘要

背景

非传染性疾病对人类健康和福祉构成重大威胁,对经济发展以及政府、企业、家庭和个人的医疗保健及其他成本产生重大影响。许多主要非传染性疾病的风险与商业生产的食品和饮料的生产、营销及消费有关,特别是那些含有糖、盐和反式脂肪(超加工产品中)、酒精和烟草的产品。非传染性疾病一级预防中固有的问题相对较少受到国际组织、国家政府和民间社会的关注,尤其是与对二级和三级预防机制(即侧重于提供医疗治疗和长期临床管理的机制)的关注相比。这可能部分反映出直到最近非传染性疾病在全球总体卫生议程中都未被视为优先事项。政治优先级较低也可能部分归因于实施可行且可接受的干预措施(如提高税收或规范获取途径)所固有的复杂性,特别是考虑到需要在卫生部门之外协调行动。更根本的是,管控风险决定因素往往使公共卫生与追求利润的食品、饮料、酒精和烟草行业的利益发生冲突。

材料

我们使用一个概念框架来审视非传染性疾病风险的三种治理模式:行业自我监管;公私合作的混合模式;以及公共部门监管。我们分析每种模式中固有的挑战,并审视关于它们对非传染性疾病结果的影响已知(或未知)的情况。

结论

虽然已经做出了一些零散的努力,但我们认为控制非传染性疾病商业决定因素的机制并不充分,补救行动的力度也过于有限。我们的论文提出了加强这三种治理模式的议程。我们确定了全球卫生架构治理非传染性疾病风险所需的改革,包括加强其整合不同利益相关者集体力量的能力、制定和执行明确的风险应对措施的权威,以及为所有行为体建立监测和基于权利的问责制度,以推动在减轻全球非传染性疾病负担方面取得可衡量、公平和可持续的进展。

相似文献

3
Addressing NCDs: Challenges From Industry Market Promotion and Interferences.
Int J Health Policy Manag. 2019 May 1;8(5):256-260. doi: 10.15171/ijhpm.2019.02.
4
Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
BMC Public Health. 2020 May 12;20(1):660. doi: 10.1186/s12889-020-08795-2.
5
Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
Int J Health Policy Manag. 2022 Jul 1;11(7):1078-1089. doi: 10.34172/ijhpm.2020.257. Epub 2021 Jan 16.
7
How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention.
Int J Health Policy Manag. 2019 Sep 1;8(9):514-520. doi: 10.15171/ijhpm.2019.56.
8
China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
Ann Glob Health. 2017 May-Aug;83(3-4):489-500. doi: 10.1016/j.aogh.2017.10.025. Epub 2017 Nov 27.
10
Nutrition related non-communicable diseases and sugar sweetened beverage policies: a landscape analysis in Zambia.
Glob Health Action. 2021 Jan 1;14(1):1872172. doi: 10.1080/16549716.2021.1872172.

引用本文的文献

1
2
Harnessing the connectivity of climate change, food systems and diets: Taking action to improve human and planetary health.
Anthropocene. 2023 Jun;42:100381. doi: 10.1016/j.ancene.2023.100381. Epub 2023 Apr 10.
3
Toward Monitoring and Addressing the Commercial Determinants of Health: Where Can We Go From Here?
Milbank Q. 2025 Jun;103(2):254-315. doi: 10.1111/1468-0009.70012. Epub 2025 May 25.
4
Gambling advertising regulation in Ghana: what do we know and where to next?
J Public Health Policy. 2025 Jun;46(2):433-443. doi: 10.1057/s41271-025-00547-z. Epub 2025 Jan 17.
5
Using a systems thinking approach to map the global rise of ultra-processed foods in population diets.
Obes Rev. 2025 Apr;26(4):e13877. doi: 10.1111/obr.13877. Epub 2024 Dec 3.
7
Industry influence on public health policy formulation in the UK: a complex systems approach.
Health Promot Int. 2024 Dec 1;39(6). doi: 10.1093/heapro/daae139.
10
Can technology be good for health? Investigating health-promoting strategies in the private sector.
Front Public Health. 2024 Sep 25;12:1395422. doi: 10.3389/fpubh.2024.1395422. eCollection 2024.

本文引用的文献

1
The commercial determinants of health.
Lancet Glob Health. 2016 Dec;4(12):e895-e896. doi: 10.1016/S2214-109X(16)30217-0.
2
WHO's Director-General candidates: visions and priorities.
Lancet. 2016 Oct 29;388(10056):2072-2095. doi: 10.1016/S0140-6736(16)31847-5. Epub 2016 Oct 13.
3
Sponsorship of National Health Organizations by Two Major Soda Companies.
Am J Prev Med. 2017 Jan;52(1):20-30. doi: 10.1016/j.amepre.2016.08.010. Epub 2016 Oct 10.
4
Sitting on the FENSA: WHO engagement with industry.
Lancet. 2016 Jul 30;388(10043):446-7. doi: 10.1016/S0140-6736(16)31141-2.
5
Designing a Healthy Food Partnership: lessons from the Australian Food and Health Dialogue.
BMC Public Health. 2016 Jul 27;16:651. doi: 10.1186/s12889-016-3302-8.
6
Analysis of the corporate political activity of major food industry actors in Fiji.
Global Health. 2016 May 10;12(1):18. doi: 10.1186/s12992-016-0158-8.
7
Tobacco, Alcohol, and Processed Food Industries - Why Do Public Health Practitioners View Them So Differently?
Front Public Health. 2016 Apr 11;4:64. doi: 10.3389/fpubh.2016.00064. eCollection 2016.
9
Reframing NCDs and injuries for the poorest billion: a Lancet Commission.
Lancet. 2015 Sep 26;386(10000):1221-1222. doi: 10.1016/S0140-6736(15)00278-0. Epub 2015 Sep 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验